JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 1, 2009; DOI: 10.1124/jpet.109.151225


0022-3565/09/3301-40-53$20.00
JPET 330:40-53, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.109.151225v1
330/1/40    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Williams, D. K.
Right arrow Articles by Papke, R. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, D. K.
Right arrow Articles by Papke, R. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-TRYPTOPHAN
*ANABASINE

NEUROPHARMACOLOGY

Differential Regulation of Receptor Activation and Agonist Selectivity by Highly Conserved Tryptophans in the Nicotinic Acetylcholine Receptor Binding Site

Dustin K. Williams, Clare Stokes, Nicole A. Horenstein, and Roger L. Papke

Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, Florida (D.K.W., C.S., R.L.P.); and Department of Chemistry, University of Florida, Gainesville, Florida (N.A.H.)

We have shown previously that a highly conserved Tyr in the nicotinic acetylcholine receptor (nAChR) ligand-binding domain (LBD) ({alpha}7 Tyr188 or {alpha}4 Tyr195) differentially regulates the activity of acetylcholine (ACh) and the {alpha}7-selective agonist 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) in {alpha}4β2 and {alpha}7 nAChR. In this study, we mutated two highly conserved LBD Trp residues in human {alpha}7 and {alpha}4β2 and expressed the receptors in Xenopus laevis oocytes. {alpha}7 Receptors with Trp55 mutated to Gly or Tyr became less responsive to 4OH-GTS-21, whereas mutation of the homologous Trp57 in β2 to Gly, Tyr, Phe, or Ala resulted in {alpha}4β2 receptors that showed increased responses to 4OH-GTS-21. Mutation of {alpha}7 Trp55 to Val resulted in receptors for which the partial agonist 4OH-GTS-21 became equally efficacious as ACh, whereas {alpha}4β2 receptors with the homologous mutation remained nonresponsive to 4OH-GTS-21. In contrast to the striking alterations in agonist activity profiles that were observed with mutations of {alpha}7 Trp55 and β2 Trp57, mutations of {alpha}7 Trp149 or {alpha}4 Trp154 universally resulted in receptors with reduced function. Our data support the hypothesis that some conserved residues in the nAChR LBD differentially regulate receptor activation by subtype-selective agonists, whereas other equally well conserved residues play fundamental roles in receptor activation by any agonist. Residues like {alpha}7 Trp149 ({alpha}4 Trp154) may be considered pillars upon which basic receptor function depends, whereas {alpha}7 Trp55 (β2 Trp57) and {alpha}7 Tyr188 ({alpha}4 Tyr195) may be fulcra upon which agonists may operate differentially in specific receptor subtypes, consistent with the hypothesis that ACh and 4OH-GTS-21 are able to activate nAChR in distinct ways.


Received for publication January 22, 2009
Accepted March 30, 2009.

Address correspondence to: Roger L. Papke, Department of Pharmacology and Therapeutics, University of Florida, P.O. Box 100267, Gainesville, FL 32610-0267. E-mail: rlpapke{at}ufl.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.